These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3051138)

  • 1. Effect of glucagon-like peptide-1 on insulin secretion.
    Shima K; Hirota M; Ohboshi C
    Regul Pept; 1988 Aug; 22(3):245-52. PubMed ID: 3051138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
    FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
    Siegel EG; Schulze A; Schmidt WE; Creutzfeldt W
    Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enteroinsular axis in dipeptidyl peptidase IV-negative rats.
    Pederson RA; Kieffer TJ; Pauly R; Kofod H; Kwong J; McIntosh CH
    Metabolism; 1996 Nov; 45(11):1335-41. PubMed ID: 8931636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
    Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
    de Heer J; Rasmussen C; Coy DH; Holst JJ
    Diabetologia; 2008 Dec; 51(12):2263-70. PubMed ID: 18795252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
    Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
    Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
    Oben J; Morgan L; Fletcher J; Marks V
    J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
    Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
    Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.